Govern the Future of Biotechnology at the Executive Level
BioStrategy Executive is a rigorous credential program for senior leaders who need to architect, defend, and govern enterprise biotechnology strategies — spanning genomics, synthetic biology, and precision medicine — and walk away with a board-ready portfolio that speaks for itself.

"The executives who complete this program don't just understand biotechnology strategy — they can stand in front of a board and defend every governance decision they've made, on the record."— Pauline Brown Smith, EdD

What you'll learn
What you'll be able to do
- Architect a phased enterprise biotechnology strategy that integrates genomics, synthetic biology, and precision medicine with measurable organizational KPIs
- Build and defend a board-ready Master Biotechnology Portfolio including a governance plan, risk register, and 5/10/20-year innovation roadmap
- Apply biosafety, bioethics, and regulatory compliance frameworks to real executive decisions and governance reviews
- Design a bioinformatics infrastructure roadmap aligned with translational research priorities and organizational investment thresholds
- Lead stakeholder engagement and present executive-level board presentations that justify innovation investments and R&D resource allocation
- Demonstrate executive competency through portfolio defense simulations, case study analysis, and evidence-based recommendations before a peer review board
How it works
A school that adapts to you
This isn't a set of static videos. Every lesson is generated live and tuned to where you actually are.
We learn your level
A quick placement check tailors your starting point so you're never bored or lost.
Lessons adapt as you go
Each lesson is written for your pace and your goal, adjusting as your skills grow.
Your AI coach keeps you moving
Checkpoints, feedback, and gentle nudges turn progress into a real result.
The curriculum
What's inside your school
5 modules · 22 lessons

Executive Biotechnology Strategy Capstone
Design and defend a comprehensive enterprise biotechnology strategy integrating genomics, synthetic biology, bioinformatics, translational research, governance, biosafety, bioethics, regulatory compliance, and measurable organizational outcomes.
- 1.1Enterprise Biotechnology Strategy DesignIncluded
- 1.2Phased Implementation and Stakeholder EngagementIncluded
- 1.3Investment Priorities and Performance MeasurementIncluded
- 1.4Continuous Improvement and Strategy DefenseIncluded
Brown Tech Master Biotechnology Portfolio
Build every component of the board-ready Master Biotechnology Portfolio, from the enterprise blueprint and genomics roadmap to the risk register, KPI dashboard, and reflective leadership journal.
- 2.1Enterprise Biotechnology Strategy BlueprintIncluded
- 2.2Genomics Roadmap and Bioinformatics FrameworkIncluded
- 2.3Biotechnology Governance Plan and Risk RegisterIncluded
- 2.4Executive KPI Dashboard and Board PresentationIncluded
- 2.5Five-, Ten-, and Twenty-Year Innovation Roadmap and Reflective Leadership JournalIncluded
Executive Competency Verification
Demonstrate executive mastery across biotechnology domains through portfolio defense simulations, governance reviews, ethics analyses, biosafety assessments, and case study presentations.
- 3.1Biotechnology Case Study AnalysisIncluded
- 3.2Governance Reviews and Ethics AnalysesIncluded
- 3.3Biosafety Assessment and Regulatory Compliance DefenseIncluded
- 3.4Board Presentation and Evidence-Based RecommendationsIncluded
Chapter Summary — Unified Executive Leadership Framework
Consolidate all program learning into a unified executive leadership framework that distinguishes established biotechnology practice from emerging research frontiers.
- 4.1Integrating Genomics, Synthetic Biology, and Precision MedicineIncluded
- 4.2Governance, Biosafety, and Bioethics as Strategic PillarsIncluded
- 4.3Translational Research and Bioinformatics in Executive PracticeIncluded
- 4.4Established Practice vs. Emerging Research — Executive DistinctionIncluded
Executive Biotechnology Portfolio Defense Simulation
Present the completed Master Biotechnology Portfolio to a simulated executive review board and defend every governance decision, research priority, biosafety practice, and innovation investment against rigorous peer scrutiny.
- 5.1Portfolio Defense Preparation and Peer Review ProtocolsIncluded
- 5.2Defending Governance Decisions and Ethics OversightIncluded
- 5.3Research Priorities, Biosafety, and Innovation Investment DefenseIncluded
- 5.4Long-Term Organizational Value Creation and Certification AlignmentIncluded
- 5.5Final Portfolio Submission and Executive Credential AwardIncluded
Who it's for
Is this you?
Chief Scientific Officers
Ready to translate deep scientific expertise into board-defensible enterprise strategy and formal governance credentials.
Directors of R&D
Leading translational research teams who need a structured framework for governance, risk, and long-term innovation investment decisions.
Healthcare Strategists
Advising health systems or life-sciences firms on precision medicine and genomics initiatives that demand regulatory and governance fluency.
Biotech C-Suite Executives
CEOs, COOs, and CFOs of biotech organizations who must govern R&D pipelines and justify innovation investment at the board level.
Translational Research Leaders
Bridging bench science and enterprise strategy, seeking a credential that formalizes their bioinformatics and governance competency.
Senior Regulatory Affairs Professionals
Credentialed compliance experts expanding their mandate into executive strategy, biosafety governance, and enterprise-level risk oversight.
Questions
Frequently asked
Your teacher
A note from your teacher
Pauline Brown Smith, EdD
If you have reached a level in your career where you are expected to make consequential calls on genomic investment, synthetic biology infrastructure, precision medicine strategy, or translational research governance — and you are doing it without a verified, structured executive framework behind you — you already know the risk you are carrying. Not the scientific risk. The governance risk. The accountability risk. The risk of defending a board recommendation without a documented, evidence-based rationale that holds under scrutiny.
That gap is what BioStrategy Executive was designed to close.
This program is not an orientation to biotechnology. It is not a leadership seminar with a certificate at the end. It is a structured executive credential experience that holds you to the standard your position already demands. You will leave with a complete Brown Tech Master Biotechnology Portfolio — a governance plan, a risk register, a bioinformatics infrastructure roadmap, a KPI dashboard, a board presentation, and a five-, ten-, and twenty-year innovation roadmap — every piece of it built by you, stress-tested through case analysis and governance review, and defended before a peer review board under conditions that mirror real executive accountability.
The curriculum integrates genomics, synthetic biology, and precision medicine not as isolated science domains, but as the strategic and governance challenges they represent at the enterprise level. Biosafety, bioethics, and regulatory compliance are woven into every governance decision you will make in this program — because in your role, they are not ancillary. They are the foundation on which every innovation investment must stand. The distinction between established practice and emerging research is treated as an executive judgment skill, not a trivia category.
I have high expectations of everyone who enters this program, and I make no apology for that. The executives who complete BioStrategy Executive are not handed a credential — they earn it by demonstrating competency under pressure. If you are prepared to do the work, I am prepared to hold you to the standard that makes this credential worth holding. The boardroom will not lower its expectations. Neither will we.
I invite you to bring your full executive judgment, your hardest questions, and your real strategic challenges into this program. That is precisely the environment in which this work is designed to be done.
— Pauline Brown Smith, EdD
Start your journey today
Join get instant access — learn at your own pace with an AI coach in your corner.
$297/mo
Recurring billing · cancel anytime
Secure checkout · Instant access
- 5 modules, 22 lessons
- AI-adaptive lessons tuned to your level
- Quizzes & checkpoints to lock in progress
- Your own AI learning coach
- Learn on any device, at your pace
- Full access for as long as you're subscribed